FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034954827> ?p ?o ?g. }

• W2034954827 abstract "CTL with optimal effector function play critical roles in mediating protection against various intracellular infections and cancer. However, individuals may exhibit suppressive immune microenvironment and, in contrast to activating CTL, their autologous antigen presenting cells may tend to tolerize or anergize antigen specific CTL. As a result, although still in the experimental phase, CTL-based adoptive immunotherapy has evolved to become a promising treatment for various diseases such as cancer and virus infections. In initial experiments ex vivo expanded CMV (cytomegalovirus) specific CTL have been used for treatment of CMV infection in immunocompromised allogeneic bone marrow transplant patients. While it is common to have life-threatening CMV viremia in these patients, none of the patients receiving expanded CTL develop CMV related illness, implying the anti-CMV immunity is established by the adoptively transferred CTL1. Promising results have also been observed for melanoma and may be extended to other types of cancer2. While there are many ways to ex vivo stimulate and expand human CTL, current approaches are restricted by the cost and technical limitations. For example, the current gold standard is based on the use of autologous DC. This requires each patient to donate a significant number of leukocytes and is also very expensive and laborious. Moreover, detailed in vitro characterization of DC expanded CTL has revealed that these have only suboptimal effector function 3. Here we present a highly efficient aAPC based system for ex vivo expansion of human CMV specific CTL for adoptive immunotherapy (Figure 1). The aAPC were made by coupling cell sized magnetic beads with human HLA-A2-Ig dimer and anti-CD28mAb4. Once aAPC are made, they can be loaded with various peptides of interest, and remain functional for months. In this report, aAPC were loaded with a dominant peptide from CMV, pp65 (NLVPMVATV). After culturing purified human CD8+ CTL from a healthy donor with aAPC for one week, CMV specific CTL can be increased dramatically in specificity up to 98% (Figure 2) and amplified more than 10,000 fold. If more CMV-specific CTL are required, further expansion can be easily achieved by repetitive stimulation with aAPC. Phenotypic and functional characterization shows these expanded cells have an effector-memory phenotype and make significant amounts of both TNFα and IFNγ (Figure 3)." @default.
• W2034954827 created "2016-06-24" @default.
• W2034954827 creator A5024667876 @default.
• W2034954827 creator A5025098412 @default.
• W2034954827 creator A5061137097 @default.
• W2034954827 date "2011-04-11" @default.
• W2034954827 modified "2023-09-26" @default.
• W2034954827 title "HLA-Ig Based Artificial Antigen Presenting Cells for Efficient <em>ex vivo</em> Expansion of Human CTL" @default.
• W2034954827 cites W1983412131 @default.
• W2034954827 cites W2015232856 @default.
• W2034954827 cites W2077521424 @default.
• W2034954827 cites W2116553226 @default.
• W2034954827 cites W2315098267 @default.
• W2034954827 cites W3140526629 @default.
• W2034954827 doi "https://doi.org/10.3791/2801" @default.
• W2034954827 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3169282" @default.
• W2034954827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21505415" @default.
• W2034954827 hasPublicationYear "2011" @default.
• W2034954827 type Work @default.
• W2034954827 sameAs 2034954827 @default.
• W2034954827 citedByCount "11" @default.
• W2034954827 countsByYear W20349548272013 @default.
• W2034954827 countsByYear W20349548272014 @default.
• W2034954827 countsByYear W20349548272015 @default.
• W2034954827 countsByYear W20349548272017 @default.
• W2034954827 countsByYear W20349548272019 @default.
• W2034954827 countsByYear W20349548272022 @default.
• W2034954827 countsByYear W20349548272023 @default.
• W2034954827 crossrefType "journal-article" @default.
• W2034954827 hasAuthorship W2034954827A5024667876 @default.
• W2034954827 hasAuthorship W2034954827A5025098412 @default.
• W2034954827 hasAuthorship W2034954827A5061137097 @default.
• W2034954827 hasBestOaLocation W20349548271 @default.
• W2034954827 hasConcept C147483822 @default.
• W2034954827 hasConcept C147969180 @default.
• W2034954827 hasConcept C150903083 @default.
• W2034954827 hasConcept C167672396 @default.
• W2034954827 hasConcept C203014093 @default.
• W2034954827 hasConcept C207001950 @default.
• W2034954827 hasConcept C2522874641 @default.
• W2034954827 hasConcept C26291073 @default.
• W2034954827 hasConcept C2776090121 @default.
• W2034954827 hasConcept C2777701055 @default.
• W2034954827 hasConcept C2779820661 @default.
• W2034954827 hasConcept C2780674031 @default.
• W2034954827 hasConcept C71924100 @default.
• W2034954827 hasConcept C86803240 @default.
• W2034954827 hasConcept C8891405 @default.
• W2034954827 hasConcept C90375314 @default.
• W2034954827 hasConceptScore W2034954827C147483822 @default.
• W2034954827 hasConceptScore W2034954827C147969180 @default.
• W2034954827 hasConceptScore W2034954827C150903083 @default.
• W2034954827 hasConceptScore W2034954827C167672396 @default.
• W2034954827 hasConceptScore W2034954827C203014093 @default.
• W2034954827 hasConceptScore W2034954827C207001950 @default.
• W2034954827 hasConceptScore W2034954827C2522874641 @default.
• W2034954827 hasConceptScore W2034954827C26291073 @default.
• W2034954827 hasConceptScore W2034954827C2776090121 @default.
• W2034954827 hasConceptScore W2034954827C2777701055 @default.
• W2034954827 hasConceptScore W2034954827C2779820661 @default.
• W2034954827 hasConceptScore W2034954827C2780674031 @default.
• W2034954827 hasConceptScore W2034954827C71924100 @default.
• W2034954827 hasConceptScore W2034954827C86803240 @default.
• W2034954827 hasConceptScore W2034954827C8891405 @default.
• W2034954827 hasConceptScore W2034954827C90375314 @default.
• W2034954827 hasIssue "50" @default.
• W2034954827 hasLocation W20349548271 @default.
• W2034954827 hasLocation W20349548272 @default.
• W2034954827 hasLocation W20349548273 @default.
• W2034954827 hasLocation W20349548274 @default.
• W2034954827 hasOpenAccess W2034954827 @default.
• W2034954827 hasPrimaryLocation W20349548271 @default.
• W2034954827 hasRelatedWork W1994953654 @default.
• W2034954827 hasRelatedWork W2034954827 @default.
• W2034954827 hasRelatedWork W2035649284 @default.
• W2034954827 hasRelatedWork W2093242067 @default.
• W2034954827 hasRelatedWork W2140647949 @default.
• W2034954827 hasRelatedWork W2155035972 @default.
• W2034954827 hasRelatedWork W2220102944 @default.
• W2034954827 hasRelatedWork W2917396455 @default.
• W2034954827 hasRelatedWork W4282973229 @default.
• W2034954827 hasRelatedWork W4292810566 @default.
• W2034954827 isParatext "false" @default.
• W2034954827 isRetracted "false" @default.
• W2034954827 magId "2034954827" @default.
• W2034954827 workType "article" @default.